- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 63.68M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 60.01M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 43.4M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $48.85K |
| Capex | Q1 2026 · Mar 31, 2025 | $42.67K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$4.41M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$4.74M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $6.3M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $3.62M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $23.19M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $20.93M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $9.86M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $6.07M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $5.92M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $6.51M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $6.42M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $6.98M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $4.62M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $29.7M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $27.35M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.13 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.15 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.13 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.15 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.3M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $2.02M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $5.23M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $4.58M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$7.54M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$6.66M |
| Revenue | Q1 2026 · Mar 31, 2026 | $0 |
| Revenue | Q1 2026 · Mar 31, 2025 | $0 |